Botanical & Plant Derived Medicine/Drugs Industry Analysis By Source (Plant, Algae, Microscopic Fungi), By Formulation(Pills, Tablets, Capsules, Injections) By Therapeutic Application( Central Nervous System, Infectious, Cardiovascular, Respiratory Diseases), By Geography

Botanical & Plant Derived Drugs Market Outlook, 2017-2025

Botanical & plant derived drugs market is witnessing growth in the pharmaceutical industry due to high side effects caused by the consumption of synthetic drugs. But the stringent law & regulations in the use & approval of botanical & plant based drugs is restricting the growth prospects. On the other hand, the huge growth prospects & anticipated rise in demand of plant based drugs in near future, multiple pharmaceutical companies are leading towards mergers & acquisitions which is thus driving the market. As per Goldstein Research, the global botanical & plant based drugs market is anticipated to reach a market size of USD 53.0 billion by 2025, growing at a CAGR of 6.50% during the forecast period 2017-2025.

Further, rising prevalence of chronic diseases coupled with low cost of plant based drugs is propelling the adoption of botanical & plant derived drugs. The unavailability of drugs to cure chronic pains has led the physicians to follow pharmacologic treatment to lower the sufferings from chronic pain. Such as it is difficult to cure intractable chronic pain but the use of botanical & plant derived drugs can help.

Our Global Botanical & Plant Derived Drugs Market can be segmented on the following basis:

Based on Source

• Plant
• Algae
• Microscopic Fungi
• Others

Based on Formulation 

• Pills
• Tablets
• Capsules
• Injections

Based on Therapeutic Application 

• Central Nervous System
• Infectious Diseases
• Cardiovascular Diseases
• Respiratory Diseases
• Others

Based on Geography 

• North America (U.S. & Canada)  Botanical & Plant Derived Drugs Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico & Rest Of Latin America)  Botanical & Plant Derived Drugs Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Hungary, Spain, Poland, Sweden & Roe)  Botanical & Plant Derived Drugs Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest Of Asia)  Botanical & Plant Derived Drugs Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, Romea) Botanical & Plant Derived Drugs Market {Market Share (%), Market Size (USD Billion)}

Global Botanical & Plant Derived Drugs Market Outlook comprises of the following data:

• Botanical & plant derived drugs market size (USD Billion) and compound annual growth rate (%), 2017-2025
• Botanical & plant derived drugs potential markets, major markets, 2017-2025
•  Botanical & plant derived drugs market drivers, challenges, growth opportunities, risk analysis, porter’s five force model and market attractiveness, 2017-2025
• Botanical & plant derived drugs market size (USD Billion) and compound annual growth rate (%), by source, 2017-2025
• Botanical & plant derived drugs market size (USD Billion) and compound annual growth rate (%), by formulation, 2017-2025
• Botanical & plant derived drugs market size (USD Billion) and compound annual growth rate (%), by therapeutic application, 2017-2025
• Botanical & plant derived drugs class analysis (Tarpenes, Morphine Alkaloids, Glycosides, Vinca Alkaloids and Ergot Alkaloids)
• Botanical & plant derived drugs under pipeline, 2016-17
• Sales of botanical & plant derived drugs, by region
• Regulatory scenario, by region
• Competitors Analysis

Worldwide there is increasing trend of producing & consuming botanical & plant derived drugs. In Korea, due to the government-led projects it drew the attention of manufacturing botanical drugs that has been invigorating domestic botanical drug industry. Although sales of these drugs vary from country to country pharmaceutical approval norms.

Some of the major players included in the botanical & plant derived drugs market report are: Abbott Laboratories, Pfizer, Lupin Ltd., Eli Lilly, Medigene, Johnson & Johnson, Novartis International AG, Glaxosmithkline, Ranbaxy Laboratories Ltd., and Leo Pharma.

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Botanical & plant derived drugs market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the Botanical & plant derived drugs market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects

This Market report can be fully customized according to your business specific requirements. Our representative will help you to get accurate, precise and economical market insights. Fill out the enquiry form and our team will reach you out.